To assess the expression of these transcription factors in responding T cells, ID8 tumor cells were injected into the peritoneal cavity, treatment with vehicle or ENT initiated 21 days later, and CD8 T cells assessed by flow cytometry after 10 days of treatment. Here, CD8A is linked to neoplasm.